AmerisourceBergen (ABC) Expected to Post Quarterly Sales of $40.49 Billion
Equities research analysts predict that AmerisourceBergen (NYSE:ABC) will announce sales of $40.49 billion for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have made estimates for AmerisourceBergen’s earnings. The lowest sales estimate is $39.86 billion and the highest is $41.32 billion. AmerisourceBergen reported sales of $37.15 billion during the same quarter last year, which indicates a positive year over year growth rate of 9%. The business is scheduled to issue its next earnings report before the market opens on Wednesday, May 2nd.
According to Zacks, analysts expect that AmerisourceBergen will report full year sales of $167.56 billion for the current financial year, with estimates ranging from $166.20 billion to $168.79 billion. For the next fiscal year, analysts anticipate that the business will report sales of $179.63 billion per share, with estimates ranging from $176.51 billion to $182.55 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that follow AmerisourceBergen.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.35 by $0.20. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The firm had revenue of $40.47 billion for the quarter, compared to analysts’ expectations of $40.42 billion. During the same quarter last year, the firm posted $1.36 EPS. The company’s revenue was up 6.0% compared to the same quarter last year.
Shares of NYSE:ABC traded up $2.03 on Friday, hitting $90.80. The company’s stock had a trading volume of 992,625 shares, compared to its average volume of 2,006,340. AmerisourceBergen has a 1 year low of $71.90 and a 1 year high of $106.27. The stock has a market cap of $19,071.66, a P/E ratio of 15.42, a PEG ratio of 1.31 and a beta of 1.06. The company has a quick ratio of 0.50, a current ratio of 0.95 and a debt-to-equity ratio of 1.61.
In other news, Chairman Steven H. Collis sold 21,350 shares of AmerisourceBergen stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $98.58, for a total value of $2,104,683.00. Following the sale, the chairman now directly owns 287,925 shares in the company, valued at approximately $28,383,646.50. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Tim G. Guttman sold 11,600 shares of AmerisourceBergen stock in a transaction that occurred on Thursday, April 5th. The stock was sold at an average price of $85.60, for a total value of $992,960.00. Following the completion of the sale, the chief financial officer now owns 56,472 shares in the company, valued at $4,834,003.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 154,809 shares of company stock worth $14,446,032. 27.30% of the stock is owned by corporate insiders.
Several hedge funds have recently modified their holdings of ABC. Hikari Tsushin Inc. purchased a new position in AmerisourceBergen during the fourth quarter valued at $106,000. Delpha Capital Management LLC purchased a new position in AmerisourceBergen during the fourth quarter valued at $137,000. Vantage Investment Advisors LLC purchased a new position in AmerisourceBergen during the fourth quarter valued at $156,000. TRUE Private Wealth Advisors purchased a new position in AmerisourceBergen during the fourth quarter valued at $203,000. Finally, IBM Retirement Fund purchased a new position in AmerisourceBergen during the fourth quarter valued at $216,000. Hedge funds and other institutional investors own 66.88% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece was published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2018/04/17/amerisourcebergen-abc-expected-to-post-quarterly-sales-of-40-49-billion.html.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.